An unpublished FDA letter now controls Echo IQ's heart-failure timetable

Echo IQ (ASX:EIQ) fell 50% after the FDA rejected EchoSolv HF's 510(k). The remaining valuation still assumes a regulatory recovery.

9 Sept 2026|6:58pm AEST

Market chart

EIQ · ECHOIQ LIMITED

Delayed close-price history through 11 September 2026.

Latest0.515-49.5%

Low 0.515 · 11 SeptHigh 1.75 · 02 July

Window 08 May to 11 SeptYahoo Finance, delayed

EIQ · ECHOIQ LIMITED chart data
Date	Close price
08 May	1.02
11 May	0.995
12 May	1.03
13 May	1.10
14 May	1.15
15 May	1.15
18 May	1.02
19 May	1.03
20 May	1.16
21 May	1.33
22 May	1.40
25 May	1.325
26 May	1.35
27 May	1.30
28 May	1.265
29 May	1.35
01 June	1.38
02 June	1.37
03 June	1.335
04 June	1.325
05 June	1.29
09 June	1.27
10 June	1.215
11 June	1.185
12 June	1.15
15 June	1.18
16 June	1.165
17 June	1.22
18 June	1.22
19 June	1.225
22 June	1.23
23 June	1.225
24 June	1.24
25 June	1.615
26 June	1.59
29 June	1.59
30 June	1.59
01 July	1.62
02 July	1.75
03 July	1.65
06 July	1.63
07 July	1.53
08 July	1.545
09 July	1.60
10 July	1.66
13 July	1.615
14 July	1.52
15 July	1.57
16 July	1.59
17 July	1.50
20 July	1.39
21 July	1.40
22 July	1.37
23 July	1.31
24 July	1.315
27 July	1.335
28 July	1.27
29 July	1.26
30 July	1.26
31 July	1.325
03 Aug	1.33
04 Aug	1.38
05 Aug	1.58
06 Aug	1.55
07 Aug	1.47
10 Aug	1.56
11 Aug	1.58
12 Aug	1.66
13 Aug	1.595
14 Aug	1.59
17 Aug	1.55
18 Aug	1.525
19 Aug	1.50
20 Aug	1.56
21 Aug	1.545
24 Aug	1.49
25 Aug	1.56
26 Aug	1.54
27 Aug	1.51
28 Aug	1.395
31 Aug	1.415
01 Sept	1.315
02 Sept	1.285
03 Sept	1.225
04 Sept	1.28
07 Sept	1.28
08 Sept	1.28
09 Sept	0.64
10 Sept	0.57
11 Sept	0.515

Latest research

Howmet Aerospace Inc.|NYSE:HWM|Industrials

Howmet shed $11 billion before GE moved a single casting order

Howmet Aerospace (NYSE:HWM) fell 10.70% after GE agreed to acquire CPP. Its valuation now depends on which casting orders move.

9 Sept 2026|12:43pm AEST

Novartis AG|NYSE:NVS|Health Care

Novartis paid $12 billion for Avidity. Its lead drug just failed Phase III

Novartis AG (NYSE:NVS) lost 13.9% after three clinical setbacks; the $42.5 billion reaction reaches far beyond one failed drug.

9 Sept 2026|9:28am AEST

COMPUTACENTER PLC|LSE:CCC|Information Technology

Computacenter's backlog quadrupled as gross margin fell to 9.6%

Computacenter (LSE:CCC) fell 7.8% after first-half profit rose 87%. Its £9.3 billion backlog is large, but cash and margin expose the quality of the growth.

9 Sept 2026|8:29am AEST

DUNELM GROUP PLC|LSE:DNLM|Consumer Discretionary

Dunelm will reinvest every pound of its £100 million cost plan

DUNELM GROUP PLC (LSE:DNLM) fell 14.27% after mapping a self-funded reset. The close now assumes that most of the spending repairs rather than lifts growth.

9 Sept 2026|5:39am AEST

CORE LITHIUM LTD|ASX:CXO|Materials

Core Lithium's first concentrate leaves Finniss's crusher as the next proof point

Core Lithium (ASX:CXO) rose 6.06% after Finniss produced first concentrate. The milestone leaves recovery, costs and BP33 funding to prove.

8 Sept 2026|9:17pm AEST